Protein Product for Treatment of Infectious Diseases and Related Inflammatory Processes

The inventors have found that CD6, a member of the Scavenger Receptor Cysteine-Rich (SRSR) superfamily expressed on human lymphocytes binds to Gram-positive and Gram-negative bacteria, as well as to other microbial structures. Thus, a CD6 product is useful for the manufacture of a medicament for therapeutic and/or preventive treatment of an infectious disease or of an inflammatory condition related to an infectious disease or to the presence of a product derived from an infectious agent in a mammal including a human. Examples of such inflammatory conditions are systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock.

Patents:
US 20,100,105,622

Inventor(s): SARRIAS FORNES MARIA ROSA [ES]; LOZANO SOTO FRANCISCO [ES]

Type of Offer: Sale



« More Medical Patents

---